| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8225145 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 6 Pages |
Abstract
This is the largest report of implanted FM migration in patients receiving concomitant ADT. Only 0.7% of the 281 treatments studied had significant marker migrations (>2 mm) throughout the course of EBRT. Consequently, the use of implanted FMs in these patients enables accurate monitoring of prostate gland position during treatment.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
David A. BSc, Jean-François PhD, Marie-Claude MD, Thu Van MD, Dominic MSc, Daniel MD,